Method for lowering blood glucose level by the administration of bioflavonoid

• US 6,096,364 A
• Filed: 10/22/1998
• Issued: 08/01/2000
• Est. Priority Date: 09/15/1998
• Status: Expired due to Term

• Current Assignee: Korea Advanced Institute of Science and Technology
• Original Assignee: Korea Advanced Institute of Science and Technology
• Inventors: Ahn, Byung-Tae, Lee, Chul-Ho, Moon, Surk-Sik, Bok, Song-Hae, Choi, Yang-Kyu, Choi, Myung-Sook, Jeong, Tae-Sook, Lee, Sae-Bom, Bae, Ki-Hwan, Lee, Eun-Sook, Kwon, Yong-Kook, Hyun, Byung-Hwa, Park, Yong-Bok
• Primary Examiner(s): Pratt, Helen
• Application Number:
  US09/177,463
• Time in Patent Office: 649 Days
• Field of Search: 426/2, 426/590, 426/548, 426/615, 426/616, 426/618, 424/439, 424/195.1, 514/866
• US Class Current: 426/590
• CPC Class Codes: A61K 31/34 having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics

Abstract

A method for lowering the blood glucose level in a mammal comprises administering an effective amount of a hesperetin or naringenin bioflavonoid.

Claims

1. A method for lowering the blood glucose level in a mammal which comprises administering an effective amount of a bioflavonoid selected from the group consisting of hesperetin, naringenin and a mixture thereof or a plant extract containing same ##STR3## wherein R¹, R², R³, R⁴, R⁵, R⁶, R⁷, R⁸ and R⁹ are each independently hydrogen;

a hydroxy group;

a C_1-9 alkoxy group optionally substituted with one or more substituents selected from the group consisting of a hydroxy, C_1-5 alkoxy, aryloxy, and phenyl group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro and amido group;

a C_5-9 cycloalkyloxy group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro and amido group;

a C_5-9 cycloalkylcarbonyloxy group substituted with 1 to 3 substituents selected from the group consisting or a hydroxy, alkoxy, aryloxy, halogen, nitro and amido group;

a C_2-10 or C_16-18 acyloxy group optionally substituted with one or more substituents selected from the group consisting of a hydroxy, C_1-5 alkoxy, aryloxy, and phenyl group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro group;

a rutinosyl group;

or a rhaminosyl group; and

X is a single or double bond to the mammal.

2. The method of claim 1, wherein the mammal is human.

3. The method of claim 2, wherein the effective amount of the bioflavonoid ranges from 0.1 to 500 mg/kg body weight/day.

4. The method of claim 1, wherein the plant extract is a vegetable or fruit extract.

5. The method of claim 4, wherein the vegetable extract is an extract of buckwheat sprout, seeds, stems, leaves or flowers.

6. The method of claim 1, wherein the bioflavonoid or plant extract is administered in the form of a pharmaceutical composition.

7. The method of claim 1, wherein the bioflavonoid or plant extract is administered in the form of an additive or a dietary supplement in food or beverage.

8. The method of claim 7, wherein the content of the bioflavonoid in the food ranges from 0.01 to 50% by weight.

9. The method of claim 7, wherein the content of the bioflavonoid in the beverage ranges from 200 to 1,000 mg per 1,000 ml of the beverage.